NO20063605L - Monoparamunitetsinduserende stoffer basert pa svekkede kanin myxomavirus - Google Patents
Monoparamunitetsinduserende stoffer basert pa svekkede kanin myxomavirusInfo
- Publication number
- NO20063605L NO20063605L NO20063605A NO20063605A NO20063605L NO 20063605 L NO20063605 L NO 20063605L NO 20063605 A NO20063605 A NO 20063605A NO 20063605 A NO20063605 A NO 20063605A NO 20063605 L NO20063605 L NO 20063605L
- Authority
- NO
- Norway
- Prior art keywords
- monoparamunity
- substances based
- inducing substances
- myxomaviruses
- attenuated rabbit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
Abstract
Den foreliggende oppfinnelsen angår monoparamunitetsinduserende stoff basert på paramimiserende virus eller viruskomponenter fra en myxomavirusstamme fiia kaniner med en typisk generell sykdom, en fremgangsmåte for produksjon av nevnte stoffer og for anvendelsen av disse som medikamenter for regulerende optimalisering av de paramimiserende aktiviteter, for profylakse og terapi av forskjellige dysfimksjoner i mermesker og dyr.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004003572A DE102004003572A1 (de) | 2004-01-23 | 2004-01-23 | Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens |
PCT/EP2005/000582 WO2005070453A1 (de) | 2004-01-23 | 2005-01-21 | Monoparamunitätsinducer basierend auf attenuierten myxomaviren des kaninchens |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20063605L true NO20063605L (no) | 2006-08-09 |
Family
ID=34800965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20063605A NO20063605L (no) | 2004-01-23 | 2006-08-09 | Monoparamunitetsinduserende stoffer basert pa svekkede kanin myxomavirus |
Country Status (16)
Country | Link |
---|---|
US (9) | US7494799B2 (no) |
EP (2) | EP1711204A1 (no) |
JP (1) | JP4846598B2 (no) |
KR (2) | KR20120076396A (no) |
CN (1) | CN1909923B (no) |
AU (1) | AU2005205912B2 (no) |
BR (1) | BRPI0506489A (no) |
CA (1) | CA2547757A1 (no) |
DE (1) | DE102004003572A1 (no) |
EA (1) | EA009937B1 (no) |
HK (1) | HK1095746A1 (no) |
IL (1) | IL176634A (no) |
NO (1) | NO20063605L (no) |
NZ (1) | NZ548189A (no) |
UA (1) | UA91501C2 (no) |
WO (1) | WO2005070453A1 (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004003572A1 (de) * | 2004-01-23 | 2005-08-18 | Bavarian Nordic A/S | Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens |
DE102005027956B4 (de) * | 2005-06-16 | 2009-10-22 | Mayr, Anton, Prof. Dr. Dr. h.c. mult. | Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen |
CN102230035B (zh) * | 2011-07-06 | 2013-02-13 | 中华人民共和国江苏出入境检验检疫局 | 兔粘液瘤病毒pcr检测试剂盒及其应用 |
JP6370082B2 (ja) * | 2014-04-07 | 2018-08-08 | キヤノン株式会社 | 情報処理装置、情報処理方法、及びプログラム |
JP2017083973A (ja) * | 2015-10-23 | 2017-05-18 | 富士通株式会社 | 表示端末装置、表示制御方法および表示制御プログラム |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5505941A (en) * | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
GB8426152D0 (en) * | 1984-10-16 | 1984-11-21 | Reckitt & Colmann Prod Ltd | Medicinal compositions |
DE4405841C1 (de) | 1994-02-23 | 1995-01-05 | Mayr Anton Prof Dr Med Vet Dr | Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
ES2153284B1 (es) | 1998-06-10 | 2001-09-01 | Fundacion Para El Estudio Y De | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. |
IL150736A0 (en) * | 2000-03-14 | 2003-02-12 | Mayr Anton | Altered strain of the modified vaccinia virus ankara (mva) |
DE60125736D1 (de) * | 2000-04-03 | 2007-02-15 | Univ Pittsburgh | Zusammensetzungen, die kälteangepasste pferdeinfluenzaviren enthaltende, für die behandlung von bestehende virusinfektionen des atmungssystems |
AUPQ846900A0 (en) * | 2000-06-29 | 2000-07-27 | Aruba International Pty Ltd | A vaccine |
WO2004019974A2 (en) * | 2002-08-30 | 2004-03-11 | Glaxo Group Limited | Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
US8663622B2 (en) * | 2002-12-16 | 2014-03-04 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Recombinant vaccine viruses expressing IL-15 and methods using the same |
US6960345B2 (en) | 2003-03-06 | 2005-11-01 | Incell Corporation, Llc | Oral vaccinia formulation |
JP4800924B2 (ja) * | 2003-03-07 | 2011-10-26 | ロバーツ リサーチ インスティテュート | 癌および慢性ウイルス感染の治療処置のための粘液腫症ウイルスの使用 |
DE102004003572A1 (de) * | 2004-01-23 | 2005-08-18 | Bavarian Nordic A/S | Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens |
DE102005027956B4 (de) | 2005-06-16 | 2009-10-22 | Mayr, Anton, Prof. Dr. Dr. h.c. mult. | Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen |
-
2004
- 2004-01-23 DE DE102004003572A patent/DE102004003572A1/de not_active Withdrawn
-
2005
- 2005-01-21 US US10/587,082 patent/US7494799B2/en not_active Expired - Fee Related
- 2005-01-21 JP JP2006550049A patent/JP4846598B2/ja not_active Expired - Fee Related
- 2005-01-21 KR KR1020127015730A patent/KR20120076396A/ko not_active Application Discontinuation
- 2005-01-21 EP EP05701103A patent/EP1711204A1/de not_active Withdrawn
- 2005-01-21 AU AU2005205912A patent/AU2005205912B2/en not_active Ceased
- 2005-01-21 UA UAA200609278A patent/UA91501C2/ru unknown
- 2005-01-21 NZ NZ548189A patent/NZ548189A/en not_active IP Right Cessation
- 2005-01-21 CN CN2005800030491A patent/CN1909923B/zh not_active Expired - Fee Related
- 2005-01-21 WO PCT/EP2005/000582 patent/WO2005070453A1/de active Application Filing
- 2005-01-21 CA CA002547757A patent/CA2547757A1/en not_active Abandoned
- 2005-01-21 EP EP10014101A patent/EP2327420A3/de not_active Withdrawn
- 2005-01-21 BR BRPI0506489-9A patent/BRPI0506489A/pt not_active IP Right Cessation
- 2005-01-21 EA EA200601361A patent/EA009937B1/ru not_active IP Right Cessation
-
2006
- 2006-06-16 KR KR1020067011956A patent/KR101209141B1/ko not_active IP Right Cessation
- 2006-06-29 IL IL176634A patent/IL176634A/en not_active IP Right Cessation
- 2006-08-09 NO NO20063605A patent/NO20063605L/no not_active Application Discontinuation
-
2007
- 2007-03-19 HK HK07102941.9A patent/HK1095746A1/xx not_active IP Right Cessation
-
2008
- 2008-02-28 US US12/039,120 patent/US7939085B2/en not_active Expired - Fee Related
- 2008-02-28 US US12/039,181 patent/US7691391B2/en not_active Expired - Fee Related
-
2010
- 2010-08-06 US US12/851,751 patent/US8142796B2/en not_active Expired - Fee Related
- 2010-09-28 US US12/892,186 patent/US8034356B2/en not_active Expired - Fee Related
- 2010-09-28 US US12/892,613 patent/US8039004B2/en not_active Expired - Fee Related
-
2011
- 2011-09-16 US US13/234,320 patent/US20120009654A1/en not_active Abandoned
- 2011-09-16 US US13/234,269 patent/US20120009217A1/en not_active Abandoned
- 2011-11-29 US US13/305,897 patent/US20120070464A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200609706A (en) | Network interface controller circuitry | |
MA28544B1 (fr) | Facteur de permissivité cellulaire pour virus, et leurs utilisations | |
LU92749I2 (fr) | Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2) | |
MA30497B1 (fr) | Anticorps et immunco-conjugues, et leurs utilisations. | |
ATE430345T1 (de) | Adaptive belichtungssteuerung | |
SG125239A1 (en) | Process for combusting fuels, in particular waste | |
NO20076360L (no) | Dengue serotype 2 attenuert stamme | |
NO20063605L (no) | Monoparamunitetsinduserende stoffer basert pa svekkede kanin myxomavirus | |
ATE550037T1 (de) | Zusammensetzungen gegen das sars-coronavirus und ihre verwendungen | |
ATE447740T1 (de) | Dynamisch erzeugtes betriebssystem für sensorennetze | |
DE502005002929D1 (de) | Orale darreichungsform enthaltend probiotische bakterien | |
ATE531529T1 (de) | Wertdokument, herstellung und prüfung von wertdokumenten | |
NO20070391L (no) | Jernsulfatbasert fosfatadsorbent | |
EA200702193A1 (ru) | Гликозилирование белков | |
WO2006078648A3 (en) | Rhinovirus vaccines | |
SE0501554L (sv) | Konstruktionselement | |
ATE485739T1 (de) | Haartrockner | |
ATE551573T1 (de) | Garvorrichtung | |
PL1703901T3 (pl) | Farmaceutyczna kompozycja zawierająca alkohol 2,4-dichlorobenzylowy i amylometakrezol | |
BR112013017014A2 (pt) | poliovacina inativada | |
DE602005004574D1 (de) | Erweiterbare BGP-Übergangsrouterarchitektur | |
SE0402228D0 (sv) | Ugnsisolering | |
TW200621800A (en) | Human immunodeficiency virus vaccine | |
BRPI0516511A (pt) | compostos orgánicos | |
ATE513955T1 (de) | Fachwerkkonstruktion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |